These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1308 related items for PubMed ID: 29051185

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The activation of mitochondrial BK potassium channels contributes to the protective effects of naringenin against myocardial ischemia/reperfusion injury.
    Testai L, Martelli A, Marino A, D'Antongiovanni V, Ciregia F, Giusti L, Lucacchini A, Chericoni S, Breschi MC, Calderone V.
    Biochem Pharmacol; 2013 Jun 01; 85(11):1634-43. PubMed ID: 23567997
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y, Gross S, Eckerle LG, Hertrich I, Busch M, Busch R, Riad A, Rauch BH, Stasch JP, Dörr M, Felix SB.
    Eur J Pharmacol; 2015 Nov 15; 767():1-9. PubMed ID: 26407652
    [Abstract] [Full Text] [Related]

  • 26. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
    Wang Y, Kudo M, Xu M, Ayub A, Ashraf M.
    J Mol Cell Cardiol; 2001 Nov 15; 33(11):2037-46. PubMed ID: 11708847
    [Abstract] [Full Text] [Related]

  • 27. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
    Kaneda K, Miyamae M, Sugioka S, Okusa C, Inamura Y, Domae N, Kotani J, Figueredo VM.
    Anesth Analg; 2008 Jan 15; 106(1):9-16, table of contents. PubMed ID: 18165545
    [Abstract] [Full Text] [Related]

  • 28. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction.
    Valtchanova-Matchouganska A, Gondwe M, Nadar A.
    Life Sci; 2004 Jul 09; 75(8):901-10. PubMed ID: 15193950
    [Abstract] [Full Text] [Related]

  • 29. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
    Sánchez JA, Rodríguez-Sinovas A, Barba I, Miró-Casas E, Fernández-Sanz C, Ruiz-Meana M, Alburquerque-Béjar JJ, García-Dorado D.
    Basic Res Cardiol; 2013 May 09; 108(3):351. PubMed ID: 23595215
    [Abstract] [Full Text] [Related]

  • 30. Exposure to cigarette smoke abrogates the beneficial effect of ischemic postconditioning.
    Bibli SI, Andreadou I, Glynos C, Chatzianastasiou A, Toumpanakis D, Zakynthinos S, Vasilakopoulos T, Iliodromitis EK, Papapetropoulos A.
    Am J Physiol Heart Circ Physiol; 2016 Nov 01; 311(5):H1321-H1332. PubMed ID: 27694220
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The β subunit of soluble guanylyl cyclase GUCY1B3 exerts cardioprotective effects against ischemic injury via the PKCε/Akt pathway.
    Wang X, Du W, Li M, Zhang Y, Li H, Sun K, Liu J, Dong P, Meng X, Yi W, Yang L, Zhao R, Hu J.
    J Cell Biochem; 2019 Mar 01; 120(3):3071-3081. PubMed ID: 30485489
    [Abstract] [Full Text] [Related]

  • 33. Impact of Ca2+-Sensitive Potassium Channels in Levosimendan-Induced Postconditioning.
    Stroethoff M, Bunte S, Raupach A, van de Snepscheut M, Torregroza C, Heinen A, Mathes A, Hollmann MW, Huhn R, Sixt SU.
    Cardiovasc Drugs Ther; 2019 Oct 01; 33(5):581-588. PubMed ID: 31705225
    [Abstract] [Full Text] [Related]

  • 34. Mediation of the Cardioprotective Effects of Mannitol Discovered, with Refutation of Common Protein Kinases.
    Torregroza C, Glashoerster CO, Feige K, Stroethoff M, Raupach A, Heinen A, Hollmann MW, Huhn R.
    Int J Mol Sci; 2021 Nov 19; 22(22):. PubMed ID: 34830353
    [Abstract] [Full Text] [Related]

  • 35. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.
    Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, Lopez BL, Koch W, Chan L, Goldstein BJ, Ma XL.
    Circulation; 2007 Mar 20; 115(11):1408-16. PubMed ID: 17339545
    [Abstract] [Full Text] [Related]

  • 36. Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury.
    Lux A, Pokreisz P, Swinnen M, Caluwe E, Gillijns H, Szelid Z, Merkely B, Janssens SP.
    J Pharmacol Exp Ther; 2016 Feb 20; 356(2):284-92. PubMed ID: 26621143
    [Abstract] [Full Text] [Related]

  • 37. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
    Hönisch A, Theuring N, Ebner B, Wagner C, Strasser RH, Weinbrenner C.
    Basic Res Cardiol; 2010 Mar 20; 105(2):155-67. PubMed ID: 19842009
    [Abstract] [Full Text] [Related]

  • 38. Postconditioning prevents reperfusion injury by activating delta-opioid receptors.
    Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z.
    Anesthesiology; 2008 Feb 20; 108(2):243-50. PubMed ID: 18212569
    [Abstract] [Full Text] [Related]

  • 39. Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.
    Bice JS, Burley DS, Baxter GF.
    J Cardiovasc Pharmacol Ther; 2014 May 20; 19(3):269-82. PubMed ID: 24572031
    [Abstract] [Full Text] [Related]

  • 40. Ischemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondria.
    Hu L, Wang J, Zhu H, Wu X, Zhou L, Song Y, Zhu S, Hao M, Liu C, Fan Y, Wang Y, Li Q.
    Cell Death Dis; 2016 May 12; 7(5):e2222. PubMed ID: 27171264
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 66.